Amgen, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1980-01-01
- Employees
- 26.7K
- Market Cap
- $175.6B
- Website
- http://www.amgen.com
Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)
- First Posted Date
- 2018-12-14
- Last Posted Date
- 2018-12-14
- Lead Sponsor
- Amgen
- Target Recruit Count
- 10
- Registration Number
- NCT03776058
A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy
- First Posted Date
- 2018-12-14
- Last Posted Date
- 2018-12-20
- Lead Sponsor
- Amgen
- Target Recruit Count
- 320
- Registration Number
- NCT03776032
A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life
- First Posted Date
- 2018-12-13
- Last Posted Date
- 2022-12-12
- Lead Sponsor
- Amgen
- Target Recruit Count
- 277
- Registration Number
- NCT03774875
- Locations
- 🇬🇧
Research Site, Stourbridge, United Kingdom
Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism
- First Posted Date
- 2018-12-13
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Amgen
- Target Recruit Count
- 48
- Registration Number
- NCT03774771
A Study to Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- Amgen
- Target Recruit Count
- 453
- Registration Number
- NCT03757013
- Locations
- 🇫🇷
Private Practice, Torcy, Torcy, France
🇫🇷Saint-Etienne Hospital, St Priest en Jarez, France
🇫🇷Private Practice 2, Antony, Antony, France
Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Amgen
- Target Recruit Count
- 50
- Registration Number
- NCT03757130
- Locations
- 🇺🇸
William D Summers MD LLC, Birmingham, Alabama, United States
🇺🇸QPS Miami Research Associates, South Miami, Florida, United States
🇺🇸Orange County Research Center, Tustin, California, United States
Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.
- Conditions
- Arthritis, Psoriatic
- Interventions
- Other: Apremilast (CC-10004) Placebo
- First Posted Date
- 2018-11-20
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Amgen
- Target Recruit Count
- 310
- Registration Number
- NCT03747939
- Locations
- 🇺🇸
West Tennessee Research Institute, llc, Jackson, Tennessee, United States
🇨🇦Dr Sabeen Anwar Medicine Professional Corporation, Windsor, Ontario, Canada
🇩🇪Charite - Universitaetsmedizin Berlin, Campus Mitte, Berlin, Germany
Expanded Access for CC-10004
- Conditions
- Bechet's Disease
- First Posted Date
- 2018-11-14
- Last Posted Date
- 2020-04-29
- Lead Sponsor
- Amgen
- Registration Number
- NCT03740516
- Locations
- 🇺🇸
Celgene, Summit, New Jersey, United States
A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome
- Conditions
- Focal Segmental Glomerulosclerosis
- Interventions
- Drug: CCX140-B
- First Posted Date
- 2018-10-12
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Amgen
- Target Recruit Count
- 5
- Registration Number
- NCT03703908
- Locations
- 🇺🇸
Los Angeles Biomedical Research Institute, Torrance, California, United States
🇺🇸University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸Utah Kidney Research Institute, Salt Lake City, Utah, United States
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
- First Posted Date
- 2018-10-10
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Amgen
- Target Recruit Count
- 245
- Registration Number
- NCT03701763
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
🇺🇸University of Alabama Birmingham, Birmingham, Alabama, United States
🇺🇸Phoenix Childrens Hospital, Phoenix, Arizona, United States